The promoter methylomes of monochorionic twin placentas reveal intrauterine growth restriction-specific variations in the methylation patterns

Scientific Reports

Volumn 6, Issue , 2016, Pages

  He, Zhiming ^a   Lu, Hanlin ^b   Luo, Huijuan ^b   Gao, Fei ^b   Wang, Tong ^b   Gao, Yu ^a   Fang, Qun ^a   Wang, Junwen ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b BGI SHENZHEN   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLATION; DNA SEQUENCE; FEMALE; FETUS; GENE EXPRESSION REGULATION; GENETICS; GENOME IMPRINTING; HUMAN; INTRAUTERINE GROWTH RETARDATION; METABOLISM; MONOZYGOTIC TWINS; PATHOLOGY; PLACENTA; PREGNANCY; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; SIGNAL TRANSDUCTION;

DNA METHYLATION; FEMALE; FETAL GROWTH RETARDATION; FETUS; GENE EXPRESSION REGULATION; GENOMIC IMPRINTING; HUMANS; PLACENTA; PREGNANCY; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION; TWINS, MONOZYGOTIC;

EID: 84957538425     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep20181     Document Type: Article

References (60)

1. Garite, T. J., Clark, R. & Thorp, J. A. Intrauterine growth restriction increases morbidity and mortality among premature neonates. Am J Obstet Gynecol 191, 481-487 (2004).
2. Koukoura, O., Sifakis, S. & Spandidos, D. A. DNA methylation in the human placenta and fetal growth (review). Mol Med Rep 5, 883-889 (2012).
3. Romo, A., Carceller, R. & Tobajas, J. Intrauterine growth retardation (IUGR): epidemiology and etiology. Pediatr Endocrinol Rev 6,332-336 (2009).
4. Ananth, C. V., Vintzileos, A. M., Shen-Schwarz, S., Smulian, J. C. & Lai, Y. L. Standards of birth weight in twin gestations stratified by placental chorionicity. Obstet Gynecol 91, 917-924 (1998).
5. Figueras, F. & Gratacos, E. Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol. Fetal Diagn Ther 36, 86-98 (2014).
6. Chernausek, S. D. Update: consequences of abnormal fetal growth. J Clin Endocrinol Metab 97, 689-695 (2012).
7. Huppertz, B. The anatomy of the normal placenta. J Clin Pathol 61, 1296-1302 (2008).
8. Novakovic, B. & Saffery, R. DNA methylation profiling highlights the unique nature of the human placental epigenome. Epigenomics 2, 627-638 (2010).
9. Nelissen, E. C., van Montfoort, A. P., Dumoulin, J. C. & Evers, J. L. Epigenetics and the placenta. Hum Reprod Update 17, 397-417 (2011).
10. Chen, P. Y. et al. Intrauterine calorie restriction affects placental DNA methylation and gene expression. Physiol Genomics 45, 565-576 (2013).
11. Serman, L. et al. The impact of 5-azacytidine on placental weight, glycoprotein pattern and proliferating cell nuclear antigen expression in rat placenta. Placenta 28, 803-811 (2007).
12. Lee, S. A. & Ding, C. The dysfunctional placenta epigenome: causes and consequences. Epigenomics 4, 561-569 (2012).
13. Maccani, M. A. & Marsit, C. J. Epigenetics in the placenta. Am J Reprod Immunol 62, 78-89 (2009).
14. Cordeiro, A., Neto, A. P., Carvalho, F., Ramalho, C. & Doria, S. Relevance of genomic imprinting in intrauterine human growth expression of CDKN1C, H19, IGF2, KCNQ1 and PHLDA2 imprinted genes. J Assist Reprod Genet 31, 1361-1368 (2014).
15. Koukoura, O. et al. Loss of imprinting and aberrant methylation of IGF2 in placentas from pregnancies complicated with fetal growth restriction. Int J Mol Med 28, 481-487 (2011).
16. Lambertini, L. et al. Differential methylation of imprinted genes in growth-restricted placentas. Reprod Sci 18, 1111-1117 (2011).
17. Turner, C. L. et al. Methylation analysis of 79 patients with growth restriction reveals novel patterns of methylation change at imprinted loci. Eur J Hum Genet 18, 648-655 (2010).
18. Banister, C. E. et al. Infant growth restriction is associated with distinct patterns of DNA methylation in human placentas. Epigenetics 6, 920-927 (2011).
19. Yuen, R. K., Penaherrera, M. S., von Dadelszen, P., McFadden, D. E. & Robinson, W. P. DNA methylation profiling of human placentas reveals promoter hypomethylation of multiple genes in early-onset preeclampsia. Eur J Hum Genet 18, 1006-1012 (2010).
20. Hogg, K., Blair, J. D., McFadden, D. E., von Dadelszen, P. & Robinson, W. P. Early onset pre-eclampsia is associated with altered DNA methylation of cortisol-signalling and steroidogenic genes in the placenta. PLoS One 8, e62969 (2013).
21. Wang, J. et al. Double restriction-enzyme digestion improves the coverage and accuracy of genome-wide CpG methylation profiling by reduced representation bisulfite sequencing. BMC Genomics 14, 11 (2013).
22. Robertson, K. D. DNA methylation and human disease. Nat Rev Genet 6, 597-610 (2005).
23. Chelbi, S. T. et al. Combination of promoter hypomethylation and PDX1 overexpression leads to TBX15 decrease in vascular IUGR placentas. Epigenetics 6, 247-255 (2011).
24. Schrey, S. et al. Leptin is differentially expressed and epigenetically regulated across monochorionic twin placenta with discordant fetal growth. Mol Hum Reprod 19, 764-772 (2013).
25. Tzschoppe, A. et al. DNA methylation of the p66Shc promoter is decreased in placental tissue from women delivering intrauterine growth restricted neonates. Prenat Diagn 33, 484-491 (2013).
26. Wang, J. et al. High resolution profiling of human exon methylation by liquid hybridization capture-based bisulfite sequencing. BMC Genomics 12, 597 (2011).
27. Gao, F. et al. Clustering of Cancer Cell Lines Using A Promoter-Targeted Liquid Hybridization Capture-Based Bisulfite Sequencing Approach. Technol Cancer Res Treat 14, 383-394 (2015).
28. Deaton, A. M. & Bird, A. CpG islands and the regulation of transcription. Genes Dev 25, 1010-1022 (2011).
29. Weber, M. et al. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 39, 457-466 (2007).
30. Blair, J. D. et al. Widespread DNA hypomethylation at gene enhancer regions in placentas associated with early-onset pre-eclampsia. Mol Hum Reprod 19, 697-708 (2013).
31. Tahiliani, M. et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930-935 (2009).
32. Kriaucionis, S. & Heintz, N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324, 929-930 (2009).
33. Huang, Y. et al. The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing. PLoS One 5, e8888 (2010).
34. Haffner, M. C. et al. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget 2, 627-637 (2011).
35. Lian, C. G. et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 150, 1135-1146 (2012).
36. Pastor, W. A. et al. Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature 473, 394-397 (2011).
37. Gordon, L. et al. Neonatal DNA methylation profile in human twins is specified by a complex interplay between intrauterine environmental and genetic factors, subject to tissue-specific influence. Genome Res 22, 1395-1406 (2012).
38. Suzuki, R. & Shimodaira, H. Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics 22, 1540-1542 (2006).
39. Kaminsky, Z. A. et al. DNA methylation profiles in monozygotic and dizygotic twins. Nat Genet 41, 240-245 (2009).
40. Cheng, Y. W. et al. High incidence of LRAT promoter hypermethylation in colorectal cancer correlates with tumor stage. Med Oncol 31, 254 (2014).
41. Hassel, J. C. et al. Lecithin retinol acyltransferase as a potential prognostic marker for malignant melanoma. Exp Dermatol 22, 757-759 (2013).
42. Ruiz, A. et al. Molecular and biochemical characterization of lecithin retinol acyltransferase. J Biol Chem, 274, 3834-3841 (1999).
43. Zhang, B., Kirov, S. & Snoddy, J. WebGestalt: An integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 33, W741-748 (2005).
44. Christian, P. & Stewart, C. P. Maternal micronutrient deficiency, fetal development, and the risk of chronic disease. J Nutr 140, 437-445 (2010).
45. Grybek, V. et al. Methylation and transcripts expression at the imprinted GNAS locus in human embryonic and induced pluripotent stem cells and their derivatives. Stem Cell Reports 3, 432-443 (2014).
46. Tchernev, V. T. et al. The Chediak-Higashi protein interacts with SNARE complex and signal transduction proteins. Mol Med 8, 56-64 (2002).
47. Neumann, L. C. et al. EFS shows biallelic methylation in uveal melanoma with poor prognosis as well as tissue-specific methylation. BMC Cancer 11, 380 (2011).
48. Ke, X. et al. Intrauterine growth restriction affects hippocampal dual specificity phosphatase 5 gene expression and epigenetic characteristics. Physiol Genomics 43, 1160-1169 (2011).
49. Meller, M., Vadachkoria, S., Luthy, D. A. & Williams, M. A. Evaluation of housekeeping genes in placental comparative expression studies. Placenta 26, 601-607 (2005).
50. Iglesias-Platas, I. et al. Altered expression of the imprinted transcription factor PLAGL1 deregulates a network of genes in the human IUGR placenta. Hum Mol Genet 23, 6275-6285 (2014).
51. Vandesompele, J. et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3, RESEARCH0034 (2002).
52. Doi, A. et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 41, 1350-1353 (2009).
53. Irizarry, R. A. et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 41, 178-186 (2009).
54. Gama-Sosa, M. A., Wang, R. Y., Kuo, K. C., Gehrke, C. W. & Ehrlich, M. The 5-methylcytosine content of highly repeated sequences in human DNA. Nucleic Acids Res 11, 3087-3095 (1983).
55. Lo, Y. M. & Chiu, R. W. Prenatal diagnosis: progress through plasma nucleic acids. Nat Rev Genet 8, 71-77 (2007).
56. Lam, L. L. et al. Factors underlying variable DNA methylation in a human community cohort. Proc Natl Acad Sci USA 109 Suppl 2, 17253-17260 (2012).
57. Sepulveda, W., Sebire, N. J., Hughes, K., Odibo, A. & Nicolaides, K. H. The lambda sign at 10-14 weeks of gestation as a predictor of chorionicity in twin pregnancies. Ultrasound Obstet Gynecol 7, 421-423 (1996).
58. Gratacos, E. et al. A classification system for selective intrauterine growth restriction in monochorionic pregnancies according to umbilical artery Doppler flow in the smaller twin. Ultrasound Obstet Gynecol 30, 28-34 (2007).
59. Zhang, G. L. et al. Discordant HIF1A mRNA levels and oxidative stress in placental shares of monochorionic twins with selective intra-uterine growth restriction. Placenta 36, 297-303 (2015).
60. Xi, Y. & Li, W. BSMAP: Whole genome bisulfite sequence MAPping program. BMC Bioinformatics 10, 232 (2009).